CSL to lay off up to 15% of workforce and spin off flu vaccine arm; shares tumble – Reuters
- CSL to lay off up to 15% of workforce and spin off flu vaccine arm; shares tumble Reuters
- Markets live updates: CSL to cut more than 3,000 jobs as it ‘simplifies’ business, spins off flu arm, ASX to fall Australian Broadcasting Corporation
- Australian biopharma firm CSL posts 14% rise in annual profit MSN
- ASX extends losses; BHP rebounds, CSL tumbles The Age
- CSL to Spin Off Vaccine Unit Seqirus, Plans $487 Million Buyback Bloomberg.com